Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05101993 · ClinicalTrials.gov registry record · NA
VCLIP Post-Market Study, Long-term Follow-up on LAA Exclusion Using AtriClip
A NA study, sponsored by AtriCure.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT05101993 is a NA study that has completed, run by AtriCure. The registered enrollment target is 156 participants.
The verdict
NCT05101993, a NA study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
Retrospective-prospective, multi-center, non-randomized, unblinded, post-market study to evaluate the long-term performance and safety of AtriClip® FLEX-V LAA and PRO•V LAA Exclusion devices for exclusion of the left atrial appendage of the heart during concomitant cardiac procedures.
Interventions
- DEVICE AtriClip
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2022-01-27 |
| Est. Completion | 2024-07-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05101993
The ClinicalTrials.gov registry entry for NCT05101993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AtriClip is the first listed.
NCT05101993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05101993 about?
NCT05101993 is a clinical study titled "VCLIP Post-Market Study, Long-term Follow-up on LAA Exclusion Using AtriClip". Retrospective-prospective, multi-center, non-randomized, unblinded, post-market study to evaluate the long-term performance and safety of AtriClip® FLEX-V LAA and PRO•V LAA Exclusion devices for exclusion of the left atrial appendage of the heart during concomitant cardiac procedures.
What is the current status of trial NCT05101993?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2022-01-27. Estimated completion is 2024-07-22.
What interventions are being tested in trial NCT05101993?
The interventions under investigation include: AtriClip (DEVICE).
Who is sponsoring clinical trial NCT05101993?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.